To examine changes in PRMT5/MEP50 function depending on the expression level of NDRG2, we performed experiments using NDRG2-specific shRNA to suppress NDRG2 expression in T-ALL cell lines. The gene discussed is PRMT5; the disease is acute lymphoblastic leukemia.